Veterans coming to Colorado--Bill Swift, Darrel Kyle, Hampton and Neagle--were easily psyched out by the effect of the altitude on their earned run averages.
Novartis announced today the early termination of the ALTITUDE trial, which was testing the effect of the direct renin inhibitor aliskiren (Rasilez, Tekturna) in type 2 diabetics at high risk for cardiovascular and renal events.